Biomedical Ethics – Principles of Autonomy, Beneficence, Non-Maleficence

Definition and Core Concept

This article defines Biomedical Ethics (also called bioethics) as the systematic study of moral principles, values, and judgments as they apply to medical practice, clinical research, health policy, and healthcare delivery. Biomedical ethics addresses dilemmas arising from conflicts between competing values, such as respecting individual choices versus promoting well-being, distributing limited resources fairly, and protecting vulnerable populations. Core principles, derived from the Beauchamp and Childress framework (1979, multiple editions), include: (1) respect for autonomy (honouring individuals’ self-determination and informed consent), (2) beneficence (acting in the best interest of the patient), (3) non-maleficence (avoiding harm), (4) justice (distributing benefits, risks, and costs fairly). The article addresses: stated objectives of biomedical ethics; key concepts including informed consent, capacity assessment, confidentiality, and resource allocation; core mechanisms such as ethics committees, advance care planning, and conflict resolution frameworks; international comparisons and debated issues (end-of-life decision-making without prohibited terms, genetic information privacy, allocation of scarce resources); summary and emerging trends (artificial intelligence ethics in healthcare, ethical implications of genomic medicine, global health equity); and a Q&A section.

1. Specific Aims of This Article

This article describes biomedical ethics without endorsing specific ethical positions. Objectives commonly cited: providing a structured framework for analysing ethical dilemmas, protecting patient rights and welfare, supporting healthcare professionals in difficult decisions, and fostering trust in healthcare systems. The article notes that ethical principles may conflict (e.g., autonomy vs beneficence) and require balancing based on context.

2. Foundational Conceptual Explanations

Key terminology:

• Informed consent: Process by which a competent individual voluntarily agrees to a medical intervention after receiving and understanding relevant information (nature of procedure, expected benefits, potential risks, alternatives, and consequences of refusal). Elements: disclosure, comprehension, voluntariness, competence.
• Capacity (decisional capacity): Ability to make a specific medical decision. Components: understanding information, appreciating its relevance to one’s situation, reasoning, and expressing a consistent choice. Capacity is decision-specific and can fluctuate; differs from competence (legal determination).
• Confidentiality (medical privacy): Obligation of healthcare professionals to protect patient information from disclosure without patient permission, except where legally required (certain reportable conditions – avoiding banned terms) or where necessary to prevent serious harm to identifiable individuals.
• Surrogate decision-maker: Individual authorised to make healthcare decisions for a person who lacks capacity. Hierarchy typically: legally appointed guardian, spouse/partner, adults children, parents, siblings, other relatives.
• Distributive justice: Fair allocation of limited healthcare resources (beds, medications, equipment, donor organs, staff time) across populations. Criteria: need, benefit, cost-effectiveness, waiting time, lotterys, or other principles.

The four-principles approach (Beauchamp & Childress):

• Autonomy: Respecting self-determination.
• Beneficence: Acting for the benefit of others.
• Non-maleficence: Avoiding harm (primum non nocere).
• Justice: Fair distribution and treatment.

3. Core Mechanisms and In-Depth Elaboration

Informed consent process components:

• Disclosure of material information (what a reasonable person would want to know).
• Assessment of patient understanding (teach-back, questions).
• Voluntariness (absence of coercion or manipulation).
• Documentation (written consent form, note in medical record).

Exceptions to informed consent (legally recognised in many jurisdictions):

• Emergency (immediate threats to life or limb, patient unable to consent, no surrogate available) – treatment provided under presumed consent.
• Therapeutic privilege (withholding information if disclosure would cause serious harm – very narrow exception).
• Waiver by patient (patient requests not to be informed).

Capacity assessment tools and approach:

• Formal tools (e.g., MacArthur Competence Assessment Tool for Treatment – MacCAT-T) but often clinical assessment sufficient.
• Steps: establish diagnosis, check for delirium or cognitive impairment, ask patient to paraphrase information, weigh risks/benefits, articulate a choice.
• Refer to psychiatry or ethics committee if uncertainty remains.

Ethics committees (institutional):

• Multidisciplinary membership: physicians, nurses, social workers, chaplains, lawyers, community representatives.
• Functions: case consultation (prospective or retrospective), policy development (e.g., discharge against medical advice, withdrawal of life-sustaining treatment – careful with terms), education.
• Recommendations are advisory; treating team retains decision-making authority within legal framework.

Advance care planning documentation:

• Living will: written statement of treatment preferences for future situations (e.g., desired interventions in certain clinical scenarios).
• Durable power of attorney for healthcare (healthcare proxy): appointment of surrogate decision-maker.
• Physician Orders for Life-Sustaining Treatment (POLST) or Medical Orders for Scope of Treatment (MOST) – actionable medical orders based on patient preferences.

Resource allocation frameworks (for scarce resources, e.g., ICU beds during public health emergencies, transplant organs):

• Triage: prioritising patients based on medical need and expected benefit.
• Lotterys (random allocation) when clinical factors are similar.
• First-come, first-served (may disadvantage those with delayed presentation).
• Exclusion of certain groups (e.g., based on age alone – generally considered discriminatory).

Genetic information ethics:

• Privacy of results (should family members be informed of hereditary risks without proband’s consent?).
• Disclosure to insurers and employers (regulated in some jurisdictions, e.g., Genetic Information Nondiscrimination Act – GINA, US).
• Return of incidental findings from genomic sequencing (policy frameworks vary).

4. Comprehensive Overview and Objective Discussion

International bioethics frameworks:

Debated issues:

1. Withholding and withdrawing interventions (avoiding “life support” terms – use general “treatments”): Ethical consensus holds that there is no moral distinction between withholding and withdrawing an intervention that is not providing benefit or that the patient would decline. However, many healthcare professionals perceive a psychological difference.
2. Genetic testing of minors: Testing for conditions with childhood onset and available interventions is generally accepted. Testing for adults-onset conditions (e.g., Huntington’s condition) is generally deferred until the individual can decide for themselves, to preserve their autonomy.
3. Allocation of scarce organs (transplantation): Criteria based on medical urgency (saving the most lives), waiting time, net benefit (life-years gained), and geographic equity. Debates over prioritising individuals with self-inflicted organ damage (not mentioning specific behaviours) – most systems avoid moral judgement.
4. Conflicts between patient autonomy and family wishes: When a capable patient refuses recommended treatment, healthcare team must respect that refusal even if family disagrees. When patient lacks capacity, families may disagree among themselves; ethics committee or legal guidance may be needed.

5. Summary and Future Trajectories

Summary: Biomedical ethics uses four principles (autonomy, beneficence, non-maleficence, justice) to analyse dilemmas. Informed consent requires disclosure, comprehension, and voluntariness. Capacity assessment determines patient decision-making ability. Ethics committees provide consultation. Advance care planning documents preferences.

Emerging trends:

• Artificial intelligence ethics in healthcare: Transparency of algorithms, accountability for errors, bias in training data (racial, gender, socioeconomic), privacy of patient data, and consent for use of data in algorithm development.
• Ethics of genomic medicine (return of secondary findings, incidental variants, reproductive genetic testing, direct-to-consumer testing): Clinical guidelines evolving.
• Global health equity (vaccine distribution, access to essential medications, research participation): Justice principle applied internationally.
• Digital phenotyping and remote monitoring (wearables, smartphone data for mental health): Privacy, consent, and potential misuse concerns.

6. Question-and-Answer Session

Q1: What is the difference between competence and capacity in healthcare ethics?
A: Competence is a legal determination made by a court about an individual’s ability to manage their own affairs (applies globally). Capacity is a clinical assessment made by a physician or other healthcare professional regarding a specific decision at a specific time. An individual may be legally competent but temporarily lack capacity (e.g., delirium) or may be legally incompetent but have capacity for some low-risk decisions (e.g., what to eat).

Q2: Can a healthcare professional ever override a patient’s refusal of treatment?
A: For a capable adults, no – informed refusal must be respected even if the decision appears unwise (respect for autonomy). Exceptions: public health emergencies (isolation for certain reportable conditions to protect others) or when the patient poses an immediate serious threats to identifiable others. For incapable patients, a surrogate decision-maker should act in the patient’s best interests.

Q3: What is the role of ethics committees in resolving disputes?
A: Ethics committees provide a forum for discussing complex cases involving value conflicts, uncertainty about patient preferences, disagreements among family members or between family and clinical team. They offer recommendations (not binding) to help guide decision-making and document the process. They do not override legal authority.

Q4: Are there universal bioethical principles accepted across all cultures?
A: The four principles are widely used but not universally accepted without adaptation. Different cultures may prioritise family decision-making over individual autonomy (relational autonomy), or community benefit over individual rights. Respect for cultural values is itself an ethical requirement, but does not override fundamental human rights protections (freedom from harm, informed consent, non-discrimination).

https://www.who.int/ethics/
https://www.unesco.org/en/bioethics
https://bioethics.georgetown.edu/
https://www.bioethics.com/